Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aric C Hall

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Oncology (Williston Park, N.Y.)|June 21, 2015
Splenic Lymphomas Presenting as SplenomegalyAric C Hall, Brad Kahl
Current Opinion in Hematology|January 14, 2015
New methods for assessing response in acute myeloid leukemiaAric C Hall, Ryan James Mattison
Nutrients|June 20, 2013
The role of vitamin D in hematologic disease and stem cell transplantationAric C Hall, Mark B Juckett
Leukemia Research Reports|April 1, 2022
Delayed kidney transplantation after HLA-haploidentical hematopoietic cell transplantation in a young woman with myelodysplastic syndrome with renal failureKevin C Miller, Aric C Hall, Abraham Cohen-Bucay, et al.
Journal of Oncology Practice|March 5, 2015
HemOnc.org: A Collaborative Online Knowledge Platform for Oncology ProfessionalsJeremy L Warner, Andrew J Cowan, Aric C Hall, et al.
Patient Education and Counseling|February 11, 2024
Balancing risks and rewards: How hematologists discuss uncertainty in allogeneic hematopoietic cell transplantation outcomesRachel A Rodenbach, Thorunn Thordardottir, Markus Brauer, et al.
JCO Oncology Practice|January 19, 2024
Communication Strategies of Transplant Hematologists in High-Risk Decision-Making ConversationsRachel A Rodenbach, Thorunn Thordardottir, Markus Brauer, et al.
Leukemia & Lymphoma|May 7, 2025
'A perfect match': how hematologists discuss donor options and risks with black and white patients considering allogeneic stem cell transplantThorunn H Thordardottir, Rachel A Rodenbach, Markus Brauer, et al.
American Journal of Hematology|June 22, 2022
Impact of autologous hematopoietic cell transplantation on disease burden quantified by next-generation sequencing in multiple myeloma treated with quadruplet therapySusan Bal, Binod Dhakal, Rebecca W Silbermann, et al.
The Lancet. Haematology|September 30, 2023
Minimal residual disease response-adapted therapy in newly diagnosed multiple myeloma (MASTER): final report of the multicentre, single-arm, phase 2 trialLuciano J Costa, Saurabh Chhabra, Eva Medvedova, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Oncology (Williston Park, N.Y.)|June 21, 2015
Splenic Lymphomas Presenting as SplenomegalyAric C Hall, Brad Kahl
Current Opinion in Hematology|January 14, 2015
New methods for assessing response in acute myeloid leukemiaAric C Hall, Ryan James Mattison
Nutrients|June 20, 2013
The role of vitamin D in hematologic disease and stem cell transplantationAric C Hall, Mark B Juckett
Leukemia Research Reports|April 1, 2022
Delayed kidney transplantation after HLA-haploidentical hematopoietic cell transplantation in a young woman with myelodysplastic syndrome with renal failureKevin C Miller, Aric C Hall, Abraham Cohen-Bucay, et al.
Journal of Oncology Practice|March 5, 2015
HemOnc.org: A Collaborative Online Knowledge Platform for Oncology ProfessionalsJeremy L Warner, Andrew J Cowan, Aric C Hall, et al.
Patient Education and Counseling|February 11, 2024
Balancing risks and rewards: How hematologists discuss uncertainty in allogeneic hematopoietic cell transplantation outcomesRachel A Rodenbach, Thorunn Thordardottir, Markus Brauer, et al.
JCO Oncology Practice|January 19, 2024
Communication Strategies of Transplant Hematologists in High-Risk Decision-Making ConversationsRachel A Rodenbach, Thorunn Thordardottir, Markus Brauer, et al.
Leukemia & Lymphoma|May 7, 2025
'A perfect match': how hematologists discuss donor options and risks with black and white patients considering allogeneic stem cell transplantThorunn H Thordardottir, Rachel A Rodenbach, Markus Brauer, et al.
American Journal of Hematology|June 22, 2022
Impact of autologous hematopoietic cell transplantation on disease burden quantified by next-generation sequencing in multiple myeloma treated with quadruplet therapySusan Bal, Binod Dhakal, Rebecca W Silbermann, et al.
The Lancet. Haematology|September 30, 2023
Minimal residual disease response-adapted therapy in newly diagnosed multiple myeloma (MASTER): final report of the multicentre, single-arm, phase 2 trialLuciano J Costa, Saurabh Chhabra, Eva Medvedova, et al.
Pageof 3